Futures on the Chinese equity index listed in Hong Kong are up more than 3% today, returning to the 9,150-point area after bouncing off the EMA200 and moving back above the EMA50 (orange line). At the start of the year, emerging markets (EM) – led by China – are performing strongly, supported by expectations of a weaker US dollar index and a broader trend toward diversification away from “expensive” Wall Street equities.
Shares of China’s Baidu jumped more than 9%, while the company’s chip unit (Biren) debuted on the Shanghai exchange, surging by around 400% on its first day of trading. Investors are now watching whether the upcoming listing of Kunluxin can replicate that success. A broad benchmark of Chinese tech stocks gained more than 4%, led by Chinese Big Tech names such as Alibaba, Baidu, JD.com, Xiaomi, and Bilibili.
CHN.cash (D1 timeframe)
Looking at the Hang Seng futures chart (CHN.cash), we can see a strong return to the broader uptrend. However, the current level may still act as a significant resistance zone, given the upper boundary of the descending channel and the EMA50 (orange line) on the daily timeframe.
-
Support: around 8,850 points (previous price reactions, EMA200)
-
Resistance: 9,150–9,200 points
A breakout above this range could potentially open the door for a move toward 10,000 points in the first half of 2026.
Source: xStation5
Daily summary: Markets recover optimism at the end of the week
Three Markets to Watch Next Week (09.01.2026)
US OPEN: Investors exercise caution in the face of uncertainty.
BREAKING: Employment in Canada better than expected! ๐๐
The material on this page does not constitute as financial advice and does not take into account your level of understanding, investment objectives, financial situation or any other particular needs.
All the information provided, including opinions, market research, mathematical results and technical analyses published on the website or transmitted to you by other means is provided for information purposes only and should in no event be interpreted as an offer of, or solicitation for, a transaction in any financial instrument, nor should the information provided be construed as advice of legal or fiscal nature.
Any investment decisions you make shall be based exclusively on your level of understanding, investment objectives, financial situation or any other particular needs. Any decision to act on information published on the website or transmitted to you by other means is entirely at your own risk. You are solely responsible for such decisions.
If you are in doubt or are not sure that you understand a particular product, instrument, service, or transaction, you should seek professional or legal advice before trading.
Investing in OTC Derivatives carries a high degree of risk, as they are leveraged based products and often small movements in the market could lead to much larger movements in the value of your investment and this could work against you or for you. Please ensure that you fully understand the risks involved, taking into account your investments objectives and level of experience, before trading, and if necessary, seek independent advice.
